Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient

S. Shah, Uzma N. Sarwar, E. A. King, A. Lat

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Chryseobacterium indologenes is a rare cause of infection in select immunosuppressed hosts. Most prior reports are from Taiwan, in patients with diabetes mellitus or malignancies. Infections caused by C. indologenes are generally associated with indwelling devices, and the organism may be resistant to many commonly utilized broad-spectrum antibiotics. We report the first case, to our knowledge, of C. indologenes subcutaneous port-related bacteremia in a liver transplant recipient. The isolates were resistant to antibiotics previously reported as active, and device removal was required for treatment success.

Original languageEnglish (US)
Pages (from-to)398-402
Number of pages5
JournalTransplant Infectious Disease
Volume14
Issue number4
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Chryseobacterium
Bacteremia
Device Removal
Anti-Bacterial Agents
Transplants
Liver
Immunocompromised Host
Infection
Taiwan
Diabetes Mellitus
Equipment and Supplies
Neoplasms
Therapeutics

Keywords

  • Chryseobacterium indologenes
  • Levofloxacin
  • Liver transplantation
  • Piperacillin/tazobactam
  • Port-related bacteremia
  • Trimethoprim/sulfamethoxazole

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Cite this

Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. / Shah, S.; Sarwar, Uzma N.; King, E. A.; Lat, A.

In: Transplant Infectious Disease, Vol. 14, No. 4, 08.2012, p. 398-402.

Research output: Contribution to journalArticle

@article{e7ac2ff4dcfb4b0599f42225bbe707f8,
title = "Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient",
abstract = "Chryseobacterium indologenes is a rare cause of infection in select immunosuppressed hosts. Most prior reports are from Taiwan, in patients with diabetes mellitus or malignancies. Infections caused by C. indologenes are generally associated with indwelling devices, and the organism may be resistant to many commonly utilized broad-spectrum antibiotics. We report the first case, to our knowledge, of C. indologenes subcutaneous port-related bacteremia in a liver transplant recipient. The isolates were resistant to antibiotics previously reported as active, and device removal was required for treatment success.",
keywords = "Chryseobacterium indologenes, Levofloxacin, Liver transplantation, Piperacillin/tazobactam, Port-related bacteremia, Trimethoprim/sulfamethoxazole",
author = "S. Shah and Sarwar, {Uzma N.} and King, {E. A.} and A. Lat",
year = "2012",
month = "8",
doi = "10.1111/j.1399-3062.2011.00711.x",
language = "English (US)",
volume = "14",
pages = "398--402",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient

AU - Shah, S.

AU - Sarwar, Uzma N.

AU - King, E. A.

AU - Lat, A.

PY - 2012/8

Y1 - 2012/8

N2 - Chryseobacterium indologenes is a rare cause of infection in select immunosuppressed hosts. Most prior reports are from Taiwan, in patients with diabetes mellitus or malignancies. Infections caused by C. indologenes are generally associated with indwelling devices, and the organism may be resistant to many commonly utilized broad-spectrum antibiotics. We report the first case, to our knowledge, of C. indologenes subcutaneous port-related bacteremia in a liver transplant recipient. The isolates were resistant to antibiotics previously reported as active, and device removal was required for treatment success.

AB - Chryseobacterium indologenes is a rare cause of infection in select immunosuppressed hosts. Most prior reports are from Taiwan, in patients with diabetes mellitus or malignancies. Infections caused by C. indologenes are generally associated with indwelling devices, and the organism may be resistant to many commonly utilized broad-spectrum antibiotics. We report the first case, to our knowledge, of C. indologenes subcutaneous port-related bacteremia in a liver transplant recipient. The isolates were resistant to antibiotics previously reported as active, and device removal was required for treatment success.

KW - Chryseobacterium indologenes

KW - Levofloxacin

KW - Liver transplantation

KW - Piperacillin/tazobactam

KW - Port-related bacteremia

KW - Trimethoprim/sulfamethoxazole

UR - http://www.scopus.com/inward/record.url?scp=84865196627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865196627&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3062.2011.00711.x

DO - 10.1111/j.1399-3062.2011.00711.x

M3 - Article

C2 - 22283924

AN - SCOPUS:84865196627

VL - 14

SP - 398

EP - 402

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 4

ER -